However, the endogenous anti-TERT T cells isolated from B-CLL normally display a very low affinity in their TCR, thus limiting their use in adoptive cell therapy (ACT) [38]. The gene discussed is TERT; the disease is B-cell chronic lymphocytic leukemia.